Northeastern University

Pan-Nanoparticle Vaccines and Therapeutics for Broad Coronavirus Protection

Dr. Christian K.O. Dzuvor, Harvard T.H. Chan School of Public Health
September 24, 2024 3:30 pm

The brutal toll of the COVID-19 pandemic underscores the need for thorough scientific or research dedications and approaches to pre-empt and counteract future pandemics. We have no precise knowledge about what viral pathogen will cause the next pandemic. However, we do know our immune system must respond and be bolstered with effective vaccines and therapeutics to protect lives against emerging viruses.  Our lab seeks to advance novel universal vaccines and therapeutics to help the world overcome future pandemics when they arise, with a focus on immunological approaches to engineer safe vaccines and broadly neutralizing antibodies from bench to bedside.

Biography: Christian is a chemical/bioengineer progressively transformed into microbiologist, viral immunologist and vaccinologist. He is a recent PhD graduate from Monash University, Australia and holds a BSc (Hons) from KNUST, Ghana. During his PhD, he worked on “Engineering protein-based nanomaterials for biomedical applications (Antibacterials, multivalent therapeutics and vaccines)”.

After his PhD, Christian joined Prof Kizzmekia S. Corbett (COVID-19 Vaccine designer and Hero) as a Postdoctoral fellow and currently harnessing viral immunology, protein engineering and nanotechnology to inform novel universal vaccines and antibody therapeutics development to tackle coronaviruses and other emerging or re-emerging viruses with pandemic-threat all in the name of Endemic preparedness at Harvard University (Harvard T.H Chan School of Public Health and Department of Immunology and Infectious Diseases).

Recent Events

March 11, 2025 3:30 pm